Mithra Pharmaceuticals Stock

Mithra Pharmaceuticals Dividend 2024

Mithra Pharmaceuticals Dividend

0 EUR

Mithra Pharmaceuticals Dividend yield

Ticker

MITRA.BR

ISIN

BE0974283153

WKN

A14V4E

How much dividend does Mithra Pharmaceuticals 2024 pay?

According to the latest status from July 2024, Mithra Pharmaceuticals paid a total of 0 EUR per share in dividends within the last 12 months. With the current Mithra Pharmaceuticals price of 0.22 EUR, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Mithra Pharmaceuticals Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Mithra Pharmaceuticals Dividend Safe?

Mithra Pharmaceuticals has been increasing the dividend for 0 years.

Over the past 10 years, Mithra Pharmaceuticals has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Mithra Pharmaceuticals's Dividend Distributions

Mithra Pharmaceuticals’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Mithra Pharmaceuticals's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Mithra Pharmaceuticals's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Mithra Pharmaceuticals’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Mithra Pharmaceuticals Aktienanalyse

What does Mithra Pharmaceuticals do?

Mithra Pharmaceuticals SA is a Belgian pharmaceutical company specializing in women's health and hormone therapy. The company was founded in 1999 by François Fornieri and Jean-Michel Foidart and has since become a major player in women's healthcare. Its unique business model covers the entire value chain of the pharmaceutical industry, including research and development, production, distribution, and marketing of its own products. Mithra Pharmaceuticals SA collaborates with other pharmaceutical companies, universities, and public research institutions worldwide, aiming to offer innovative products and services based on new technologies and scientific knowledge. The company's divisions include hormone therapy, contraception, gynecology, and dermatology, providing a wide range of products and services tailored to women's needs. One of its notable products is the Estetrol patch, a safe and effective contraceptive containing a natural estrogen hormone produced during pregnancy. In gynecology, Mithra Pharmaceuticals SA offers products for the treatment of menstrual disorders, endometriosis, and vaginal dryness, such as the Estelle pill concept, which combines contraception and hormone regulation. In dermatology, the company provides skincare products based on natural ingredients, specifically designed for women with sensitive skin or skin issues. Overall, Mithra Pharmaceuticals SA focuses on meeting the needs of women and has a history of adapting to market conditions and offering innovative products and services. With its global presence and innovative products, Mithra Pharmaceuticals SA is well-positioned for future success. Mithra Pharmaceuticals is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Mithra Pharmaceuticals stock

How much dividend does Mithra Pharmaceuticals pay?

Over the past 12 months, Mithra Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mithra Pharmaceuticals is expected to pay a dividend of 0 EUR.

What is the dividend yield of Mithra Pharmaceuticals?

The current dividend yield of Mithra Pharmaceuticals is .

When does Mithra Pharmaceuticals pay dividends?

Mithra Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Mithra Pharmaceuticals?

Mithra Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Mithra Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Mithra Pharmaceuticals located?

Mithra Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mithra Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mithra Pharmaceuticals from 7/20/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 7/20/2024.

When did Mithra Pharmaceuticals pay the last dividend?

The last dividend was paid out on 7/20/2024.

What was the dividend of Mithra Pharmaceuticals in the year 2023?

In the year 2023, Mithra Pharmaceuticals distributed 0 EUR as dividends.

In which currency does Mithra Pharmaceuticals pay out the dividend?

The dividends of Mithra Pharmaceuticals are distributed in EUR.

Andere Kennzahlen von Mithra Pharmaceuticals

Our stock analysis for Mithra Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mithra Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.